2017•Annals of OncologyOpen access

Serial genotypic characterization of circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) undergoing treatment with abiraterone acetate (abi) or enzalutamide (enza)

Nazlı Dizman, Jaymala Patel, Miaoling He, Brad Foulk, Denis A. Smirnov, Joann Hsu, P. Twardowski, Marcin T. Kortylewski, Vipul Bhargava, Jeremy O. Jones, Sumanta Kumar Pal

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Enzalutamide, Medicine, Prostate cancer, Oncology, Circulating tumor cell, Internal medicine, Cancer, Bioinformatics

Back to paper search Browse research topics Original source

Serial genotypic characterization of circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) undergoing treatment with abiraterone acetate (abi) or enzalutamide (enza) — Research Paper | ScholarLens